Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis. The current study aimed to evaluate the efficacy and safety of pangenotypic regimens in this difficult-to-trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarębska-Michaluk, Dorota, Jaroszewicz, Jerzy, Parfieniuk-Kowerda, Anna, Janczewska, Ewa, Dybowska, Dorota, Pawłowska, Małgorzata, Halota, Waldemar, Mazur, Włodzimierz, Lorenc, Beata, Janocha-Litwin, Justyna, Simon, Krzysztof, Piekarska, Anna, Berak, Hanna, Klapaczyński, Jakub, Stępień, Piotr, Sobala-Szczygieł, Barbara, Citko, Jolanta, Socha, Łukasz, Tudrujek-Zdunek, Magdalena, Tomasiewicz, Krzysztof, Sitko, Marek, Dobracka, Beata, Krygier, Rafał, Białkowska-Warzecha, Jolanta, Laurans, Łukasz, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347334/
https://www.ncbi.nlm.nih.gov/pubmed/34362064
http://dx.doi.org/10.3390/jcm10153280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347334/
https://www.ncbi.nlm.nih.gov/pubmed/34362064
http://dx.doi.org/10.3390/jcm10153280

Ejemplares similares